Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: December 12, 2019
Reporting Period: Specific event date of December 12, 2019
This filing reports a specific event under Item 8.01 (Other Events) regarding the Company's pharmaceutical supplier relationship with the Department of Veterans Affairs (VA). The filing includes a press release issued on the same date as an exhibit.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The report focuses solely on the issuance of a press release concerning the pharmaceutical supplier relationship with the Department of Veterans Affairs.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) discussing the relationship with the Department of Veterans Affairs. The text of the press release is not included in the provided input, so specific commentary, outlook, or risk details regarding this relationship are not available in this summary.
Unusual Items: The filing identifies the VA supplier relationship update as the primary event of note.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific details on the Department of Veterans Affairs pharmaceutical supplier relationship.
- Verify if the relationship update impacts future revenue streams or regulatory compliance obligations.
- Check subsequent filings for any financial impact resulting from the event reported on December 12, 2019.